Item 8.01 Other Events.

On June 1, 2023, Cyclerion Therapeutics, Inc. (the "Company") issued a press release announcing that it had regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). The full text of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits

Exhibit No.                                 Description

  99.1           Press Release of Cyclerion Therapeutics, Inc. dated June 1, 2023
104            Cover Page Interactive Data File



                                       2

--------------------------------------------------------------------------------




                                       3

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses